Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Haynes

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
Pharmacoepidemiology and Drug Safety|June 27, 2013
Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed DatabaseVincent Lo Re, Kevin Haynes, David Goldberg, et al.
JAMA Cardiology|March 19, 2020
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) TrialGuillaume Marquis-Gravel, Matthew T Roe, Holly R Robertson, et al.
Eclinicalmedicine|April 10, 2023
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort studyErica A Voss, Azza Shoaibi, Lana Yin Hui Lai, et al.
The New England Journal of Medicine|May 17, 2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular DiseaseW Schuyler Jones, Hillary Mulder, Lisa M Wruck, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
Pharmacoepidemiology and Drug Safety|June 27, 2013
Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed DatabaseVincent Lo Re, Kevin Haynes, David Goldberg, et al.
JAMA Cardiology|March 19, 2020
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) TrialGuillaume Marquis-Gravel, Matthew T Roe, Holly R Robertson, et al.
Eclinicalmedicine|April 10, 2023
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort studyErica A Voss, Azza Shoaibi, Lana Yin Hui Lai, et al.
The New England Journal of Medicine|May 17, 2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular DiseaseW Schuyler Jones, Hillary Mulder, Lisa M Wruck, et al.
Pageof 17